Ovid Therapeutics Inc share price logo

Ovid Therapeutics Inc Share Price

NASDAQ: OVID

Small Cap

$2.62

-0.04

(-1.50%)

Live

as on

Ovid Therapeutics Inc Stock Performance

as on April 24, 2026 at 1:10 am IST

  • Day's High

    $2.62
    $2.73

    4.20%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.27
    $3.11
    downward going graph

    89.69%

    Downside

    18.51%

    Upside

    downward going graph

Ovid Therapeutics Inc share price movements today

Previous Close
$2.66
Open
$2.70
Volume
486.7K
Day's Low - High
$2.62 - $2.73
52 Week Low - High
$0.27 - $3.11

Ovid Therapeutics Inc Historical Returns

1 Month Return
+ 4.31 %
3 Month Return
+ 57.4 %
1 Year Return
+ 718.46 %
3 Year Return
-17.39 %
5 Year Return
-27.52 %

Ovid Therapeutics Inc Stock Fundamentals & Key Indicators

Check Ovid Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$526.2M

EPS (TTM)

-0.4157

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-42.2M

Revenue (TTM)

7.3M

Profit Margin

-240.13%

Return On Equity TTM

-17.51%

Ovid Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Ovid Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$526.2M-27.52%NA-240.13%
BUY$41.2B127.17%131.818.45%
BUY$111.1B100.86%28.532.94%
NA$34.7BNA126.485.37%
BUY$79.0B52.79%18.0231.41%

Stock Returns calculator for Ovid Therapeutics Inc Stock including INR - Dollar returns

The Ovid Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Ovid Therapeutics Inc investment value today

Current value as on today

₹8,76,940

Returns

₹7,76,940

(+776.94%)

Returns from Ovid Therapeutics Inc Stock

₹6,93,939 (+693.94%)

Dollar Impact

₹83,001 (+83%)

Analyst Recommendation on Ovid Therapeutics Inc Stock

Based on 16 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 16 analysts, 87.5% of analysts recommend a 'BUY' rating for Ovid Therapeutics Inc. Average target price of $5.25

Ovid Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Ovid Therapeutics Inc.

What analysts predicted

50.1%UPSIDE

Target Price

$5.25

Current Price

$2.62

Analyzed by

16 Analysts

Target

$5.25

Ovid Therapeutics Inc target price $5.25, a slight upside of 50.1% compared to current price of $2.62. According to 16 analysts rating.

Ovid Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Ovid Therapeutics Inc Stock has decreased by -19% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-19% versus previous 30 day period

Ovid Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
0
0
0
0
0
0
0
6
0
0
Gross Profit
0
0
0
0
0
0
0
6
0
0
Operating Income
-12
-18
-17
-20
-13
-10
-12
-5
-12
-12
EBITDA
-11
-16
-17
-20
-13
-10
-12
-4
-12
-12
Interest Expense
-
1,536
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-11
-15
-11
8
-14
-9
-10
-4
-12
9
Income Tax Expense
0
0
0
-
-
-
-
-
-
-
Net Income
-11
-15
-11
8
-14
-9
-10
-4
-12
9
Net Profit Margin
-10323.85%
-10790.14%
-7901.35%
5042.01%
-8095.95%
-12175.00%
-7873.08%
-74.68%
-9210.61%
1345.96%

Ovid Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
12
208
1
0
0
7
Gross Profit
0
0
0
0
12
208
1
0
0
6
Operating Income
-22
-65
-52
-61
-81
124
-55
-59
-61
-42
EBITDA
-22
-64
-52
-61
-81
124
-54
-57
-57
-42
Interest Expense
-
-
-
-
-
0
2
-
-
-
Depreciation
-
0
0
0
0
0
1
1
0
0
Income Before Tax
-22
-64
-51
-60
-81
124
-54
-52
-26
-17
Income Tax Expense
0
0
0
-1
0
1
-2
0
-
-
Net Income
-22
-64
-51
-59
-80
122
-51
-52
-26
-17
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
-639.83%
58.95%
-3420.95%
-13351.79%
-4670.14%
-240.13%

Ovid Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-15
-11
8
-14
-9
-10
-4
-12
9
Operating Cash Flow
-11
-16
-14
-15
-10
-10
-4
-12
-10
Investing Cash Flow
-48
20
12
0
21
5
12
5
-72
Financing Cash Flow
30
0
0
0
-
0
-
0
75
Change in Cash
-30
3
-1
-14
11
-5
7
-7
-7

Ovid Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-64
-51
-60
-81
119
-54
-52
-26
-17
Operating Cash Flow
-31
-45
-51
-51
118
-55
-45
-55
-38
Investing Cash Flow
0
-5
-30
34
-1
-87
-2
54
-49
Financing Cash Flow
66
0
86
47
0
0
30
0
75
Change in Cash
35
-50
5
30
115
-142
-17
0
-13

Global Institutional Holdings in Ovid Therapeutics Inc

Funds
Holdings
Geode Capital Management, LLC
0.45%
Bvf Inc
5.42%
Ally Bridge Group (NY) LLC
1.18%
Kennedy Capital Management Inc
2.11%
Acadian Asset Management LLC
3.21%

Insights on Ovid Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, OVID stock has moved up by 57.4%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -12.15M → 9.66M (in $), with an average increase of 225.8% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, OVID has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 132.0K → 718.0K (in $), with an average increase of 81.6% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 48.4% return, outperforming this stock by 65.8%

About Ovid Therapeutics Inc

Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of small molecule medicines for brain disorders including epilepsies and seizure-related neurological disorders in the United States. The company is developing OV329, a GABA-AT inhibitor which is in Phase 1 clinical trials for the treatment of adult and infant drug-resistant epilepsies; and OV4071, a first-in-human oral potassium-chloride cotransporter 2 direct activator which is in Phase 1 clinical trials for the treatment of psychosis associated with parkinson's disease, lewy body dementia, and acute schizophrenia. It has license and collaboration agreements with AstraZeneca AB, H. Lundbeck A/S, Northwestern University, and Graviton, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.
OrganisationOvid Therapeutics Inc
HeadquartersHudson Commons, New York, NY, United States, 10001
IndustryBiotechnology
CEOMs. Margaret Alexander
E-voting on sharesClick here to vote

Key Management of Ovid Therapeutics Inc

Name

Title

Ms. Margaret Alexander

CEO, President & Director

Mr. Jeffrey A. Rona

Chief Business & Financial Officer and Corporate Secretary

Dr. Petra Kaufmann M.D., M.S.

Chief Medical Officer

Ms. Victoria Fort

Senior Vice President of Corporate Affairs & Corporate Strategy

Mr. Charles Ross Carter

Senior VP of Finance & Financial Planning

Dr. Jeremy Max Levin Ba Zoology, Dphil, M.D., Mb Bchir, Ph.D.

Co-Founder & Executive Chairman

Dr. Zhong Zhong Ph.D.

Chief Scientific Officer

Dr. Julia Tsai Ph.D.

Senior Vice President of Clinical Development

Dr. Toshiya Nishi D.V.M.

Head of Epilepsy Research

Dr. Manal Morsy M.B.A., M.D., PH.D.

Chief Regulatory Officer

FAQs

What is Ovid Therapeutics Inc share price today?

Ovid Therapeutics Inc share price today is $2.62 as on . Ovid Therapeutics Inc share today touched a day high of $2.73 and a low of $2.62.

What is the 52 week high and 52 week low for Ovid Therapeutics Inc share?

Ovid Therapeutics Inc share touched a 52 week high of $3.11 on and a 52 week low of $0.27 on . Ovid Therapeutics Inc stock price today i.e. is trending at $2.62,which is 15.62% down from its 52 week high and 870.01% up from its 52 week low.

What is Ovid Therapeutics Inc's market capitalisation today?

Ovid Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Ovid Therapeutics Inc Stock (OVID) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Ovid Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ovid Therapeutics Inc Shares that will get you 0.5725 shares as per Ovid Therapeutics Inc share price of $2.62 per share as on April 23, 2026 at 7:40 pm IST.

What is the minimum amount required to buy Ovid Therapeutics Inc Stock (OVID) from India?

Indian investors can start investing in Ovid Therapeutics Inc (OVID) shares with as little as ₹94.085 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹940.85 in Ovid Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Ovid Therapeutics Inc share’s latest price of $2.62 as on April 23, 2026 at 7:40 pm IST, you will get 3.8168 shares of Ovid Therapeutics Inc. Learn more about fractional shares .

What are the returns that Ovid Therapeutics Inc has given to Indian investors in the last 5 years?

Ovid Therapeutics Inc stock has given -27.52% share price returns and 23.96% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?